Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

126.24 -0.23 (-0.18%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,644,418
Open 128.49
Bid (Size) 126.05 (4)
Ask (Size) 126.45 (2)
Prev. Close 126.47
Today's Range 124.25 - 128.49
52wk Range 115.03 - 217.25
Shares Outstanding 384,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Wall Street Expects These Stocks to Soar 175% and 545%. Should You Buy?
These companies haven't given up on the coronavirus vaccine market. 
Via The Motley Fool

Performance

YTD
-29.47%
-29.47%
1 Month
-5.00%
-5.00%
3 Month
-8.70%
-8.70%
6 Month
-28.02%
-28.02%
1 Year
-13.14%
-13.14%

More News

Read More
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
7 Top Stock Tips for June 2023
Via InvestorPlace
7 Stocks That Even Company Insiders are Selling
Via InvestorPlace
Looking At Moderna's Recent Unusual Options Activity
Via Benzinga
What's Going On With Moderna Shares Today?
Via Benzinga
Moderna Inc. (NASDAQ: MRNA) is a Leading Gainer in Tuesday Morning Trading
Via Investor Brand Network
GeoVax's Next-Gen Single Dose COVID-19 Vaccine Shows Promising Results
Via Benzinga
As Debt Ceiling Talks Wobble, Investors Look To May Fed Minutes, Nvidia Earnings For Direction
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Is Moderna Stock a Buy Now?
Via The Motley Fool
3 Stocks You'll Be Glad You Bought at These Prices
Via The Motley Fool
Here's How Much $100 Invested In Moderna 5 Years Ago Would Be Worth Today
Via Benzinga
Looking At Moderna's Recent Unusual Options Activity
Via Benzinga
Here's Why I Still Own Alexandria Real Estate Equities
Via The Motley Fool
Hero or Zero? 3 High-Risk Biotech Stocks to Make You Rich … or Broke.
Via InvestorPlace
WHO Recommends New COVID Booster Shots To Target XBB Variants, Despite Slower Uptake
Via Benzinga
Biotech Stocks Are Already Risky -- Now There Are 3 New Headwinds to Face in 2023
Via The Motley Fool
Phase 1/2 Interim Data on Moderna's mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia (PA), Presented at the 2023 ASGCT Annual Meeting
Via ACCESSWIRE
Here's How Moderna Turned a Profit in Q1 Despite Its Sales Declining by 69%
Via The Motley Fool
Vertex Pharmaceuticals Hits Record High on Strong Q1 Earnings
Via MarketBeat
Exposures Product Safety
Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential
Via MarketBeat
Exposures Product Safety
3 Magnificent Growth Stocks to Buy to Help Build a Millionaire Portfolio
Via The Motley Fool
Google CEO Sundar Pichai Predicts That This Profession Will Be Most Revolutionized By AI
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.